EVAXION AS EVAX
SPONSORED ADS · ADR · CUSIP 29970R303
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
9
institutional holders
-1 vs Q1 2025
119.8k
shares reported held*
$293.4kreported value*
0 new
1 added
3 reduced
1 sold out
net sold ≈ $42.4k (-17.3k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.45.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2024 | 1 |
| Q1 2025 | 10 |
| Q2 2025 | 9 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2025 | 10 | 0 |
| Q2 2025 | 1 | 4 |
Biggest buyers
| RHUMBLINE ADVISERS | Added | +7.2k |
Biggest sellers
| XTX Topco Ltd | Sold out | -16.3k |
| UBS Group AG | Reduced | -4.5k |
| SBI Securities Co., Ltd. | Reduced | -2.4k |
| GAMMA Investing LLC | Reduced | -1.4k |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Ikarian Capital, LLC 0.06% of their portfolio | 80.0k $196.0k | Unchanged |
| BOOTHBAY FUND MANAGEMENT, LLC 0.00% of their portfolio | 23.7k $58.1k | Unchanged |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 9.4k $23.1k | Added +7.2k |
| GAMMA Investing LLC 0.00% of their portfolio | 3.5k $8.6k | Reduced -1.4k |
| UBS Group AG 0.00% of their portfolio | 2.0k $5.0k | Reduced -4.5k |
| Beacon Capital Management, LLC 0.00% of their portfolio | 972 $2.4k | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 64 $157 | Reduced -2.4k |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 25 $61 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |